Press Releases on September 10, 2022 - EIN Presswire - Press Release Distribution Service

Published on September 10, 2022 - 07:39 GMT

A prize of approximately $73 million - A $65 million jackpot and an estimated 8 Maxmillions in the next Lotto Max draw

MONTRÉAL, Sept. 10, 2022 /CNW Telbec/ - In the next Lotto Max draw, slated for Tuesday, September 13, the prize pool will amount to $73 million and include a $65 million jackpot and an estimated 8 Maxmillions. Lotto Max continues to churn out winners in …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Haivision Introduces New Features to its Low Latency End-to-End 5G Remote Production Solutions

Haivision mobile video encoders, transmitters, and receivers now support pristine and low latency mobile contribution in 4K and HDR for live broadcast workflows AMSTERDAM (PRWEB) September 10, 2022 Haivision Systems Inc. ("Haivision") HAI, a …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Personalized Wellness App gWell Featured on Educational Series 'Viewpoint with Dennis Quaid'

gWell: Future of Healthcare - Leading Innovation in Personalized Wellness Solutions MIAMI (PRWEB) September 10, 2022 Released to stations nationwide, one of Viewpoint with Dennis Quaid's latest short episodes features gWell, Inc., "a Boston-based …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Personalized Wellness App gWell Featured on Educational Series 'Viewpoint with Dennis Quaid'

gWell: Future of Healthcare - Leading Innovation in Personalized Wellness Solutions MIAMI, Sept. 10, 2022 /PRNewswire-PRWeb/ -- Released to stations nationwide, one of Viewpoint with Dennis Quaid's latest short episodes features gWell, Inc., "a …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Haivision Introduces New Features to its Low Latency End-to-End 5G Remote Production Solutions

Haivision mobile video encoders, transmitters, and receivers now support pristine and low latency mobile contribution in 4K and HDR for live broadcast workflows AMSTERDAM, Sept. 10, 2022 /PRNewswire-PRWeb/ -- Haivision Systems Inc. ("Haivision") …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

PayBito Listed as The Top White Label Crypto Exchange Provider by a Global Tech Research Firm

Globally acclaimed digital assets exchange PayBito won the top position in the white label crypto exchange providers category in a worldwide tech research listing. PALO ALTO, Calif., Sept. 10, 2022 /PRNewswire-PRWeb/ -- International crypto exchange …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Haivision, Nokia, and Media Broadcast Demonstrate Joint Solution for Mobile and Wireless TV Production Over a 5G Campus Network at ...

200ms Latency transmission between the camera and control room provides near real-time viewing experience. AMSTERDAM, September 10, 2022 /PRNewswire-PRWeb/ --Haivision Systems Inc. ("Haivision") HAI, a leading global provider of mission-critical …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Exelixis Announces Dose-Escalation Results from the Phase 1 STELLAR-001 Trial Evaluating XL092 Alone and in Combination with an ...

– Both single-agent XL092 and XL092 in combination with atezolizumab demonstrated encouraging efficacy and safety in a heavily pretreated patient population – – XL092 demonstrated preliminary clinical activity similar to that observed with cabozantinib in …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Anaveon presents updated data from the Phase I/II study of ANV419 during the ESMO Congress 2022

- ANV419 is well-tolerated at high doses and demonstrates notable safety with strong pharmacodynamic effects and excellent IL-2Rbg selectivity – - A Phase II program of ANV419 has been initiated in Melanoma and multiple combination trials, including in …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Wugen Presents Preclinical Data on WU-NK-101 in Solid Tumor Models at the European Society for Medical Oncology (ESMO) Congress ...

-- WU-NK-101 exhibited enhanced metabolic fitness and adaptability, enabling superior resilience within the immunosuppressive solid tumor microenvironment and preserved cytotoxic function -- -- WU-NK-101 demonstrated robust anti-tumor activity, tumor …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Haivision, Nokia, and Media Broadcast Demonstrate Joint Solution for Mobile and Wireless TV Production Over a 5G Campus Network at ...

200ms Latency transmission between the camera and control room provides near real-time viewing experience. AMSTERDAM (PRWEB) September 10, 2022 Haivision Systems Inc. ("Haivision") HAI, a leading global provider of mission-critical, real-time …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

PayBito Listed as The Top White Label Crypto Exchange Provider by a Global Tech Research Firm

Globally acclaimed digital assets exchange PayBito won the top position in the white label crypto exchange providers category in a worldwide tech research listing. PALO ALTO, Calif. (PRWEB) September 10, 2022 International crypto exchange PayBito made …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO ...

Newly published poster on the single-arm 27-patient safety and dosimetry lead-in provides key updates including: A median rPFS time of 11.5 months A best radiographic objective response (CR, PR) was achieved in 60% of the 10 participants with evaluable …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Immatics Presents Comprehensive Preclinical Data Set for TCR Bispecific Candidate IMA402 Targeting PRAME at European Society for ...

TCER® IMA402 is a next-generation, half-life extended TCR Bispecific targeting an HLA-A*02:01-presented peptide derived from PRAME In preclinical studies, IMA402 demonstrated enhanced anti-tumor activity in vivo and reduced T cell engager-associated …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

New Late-Breaking Results from Phase 3 Trials of SKYRIZI® (risankizumab) Evaluating Long-term Effect on Skin and Joint Symptoms in ...

- Analyses included 100-week efficacy and safety data from the four-year, open-label extension period of KEEPsAKE 1 and 2 evaluating SKYRIZI in patients with active psoriatic arthritis1 - Ongoing treatment with SKYRIZI demonstrated consistent long-term …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Bristol Myers Squibb Announces New Sotyktu™ (deucravacitinib) Long-Term Data Showing Clinical Efficacy Maintained for Up to Two ...

Results add to the growing body of evidence and reinforce the efficacy profile of Sotyktu, a once-daily, oral, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of moderate-to-severe plaque psoriasis New analysis to be presented at …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Novel Regeneron Bispecific Antibodies Show Encouraging Anti-tumor Activity in Two Advanced Solid Tumors

First-in-class Phase 1 data presented at ESMO for ubamatamab (REGN4018; MUC16xCD3) in recurrent ovarian cancer and REGN5093 (METxMET) in MET-altered advanced non-small cell lung cancer TARRYTOWN, N.Y., Sept. 10, 2022 /PRNewswire/ -- Regeneron …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line ...

Tislelizumab demonstrated non-inferiority for overall survival and favorable safety profile versus sorafenib in global Phase 3 trial Additional poster presentations show breadth of tislelizumab global clinical development program as single-agent treatment …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III ...

Results from two parallel trials show Cosentyx® (secukinumab) demonstrated superior efficacy vs placebo with statistically significant improvement in hidradenitis suppurativa (HS) signs and symptoms1 Safety results were consistent with the well-established …

Distribution channels: Banking, Finance & Investment Industry

Published on September 10, 2022 - 07:39 GMT

Merck and Eisai Present Results From Phase 3 LEAP-002 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Versus ...

Findings to be featured in a late-breaking proffered paper session at European Society for Medical Oncology (ESMO) Congress 2022 Merck MRK, known as MSD outside of the United States and Canada, and Eisai today announced the first presentation of results …

Distribution channels: Banking, Finance & Investment Industry